Literature DB >> 17258714

Increased risk of pregnancy-induced hypertension in young recipients of donated oocytes.

Debbra A Keegan1, Lewis C Krey, Hung-Chi Chang, Nicole Noyes.   

Abstract

OBJECTIVE: To assess the rates of select obstetric outcomes in oocyte donation (OD) recipients aged <35 years and > or =40 years and compare them to similarly aged IVF patients.
DESIGN: Retrospective anonymous questionnaire study.
SETTING: University-based IVF center. PATIENT(S): Live-birth outcome was experienced by 199 OD recipients and 488 IVF patients <35 or > or =40 years. INTERVENTION(S): The OD or IVF cycles. MAIN OUTCOME MEASURE(S): Response rate, pregnancy outcome, and complications. RESULT(S): Response rate was 60%. The OD recipients had significantly higher rates of pregnancy-induced hypertension (PIH) than their IVF counterparts. The OD <35 years had the highest rate (42%), followed by OD > or =40 years (26%), IVF > or =40 years (14%), and IVF patients <35 years (12%). In twin pregnancies, the rates of PIH remained higher in the OD groups: OD <35 years (56%), OD > or =40 years (36%), IVF > or =40 years (25%), and IVF <35 years (22%). Twin pregnancy rate was lowest in IVF patients > or =40 years (19%) and a lower preterm delivery rate (16%) reflected this difference. The cesarean section rates were 50% for singleton and 78% for twin deliveries in the OD patients <35 year; in OD patients > or =40 years, the rates were 75% and 84%, respectively. CONCLUSION(S): The OD recipients are at higher risk for untoward obstetric outcomes than their IVF counterparts. Young OD recipients reported the highest rate of PIH, warranting further investigation into an association between early loss of ovarian function and PIH.

Entities:  

Mesh:

Year:  2007        PMID: 17258714     DOI: 10.1016/j.fertnstert.2006.08.105

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  16 in total

1.  Oocyte donation: a risk factor for pregnancy-induced hypertension: a meta-analysis and case series.

Authors:  Ulrich Pecks; Nicolai Maass; Joseph Neulen
Journal:  Dtsch Arztebl Int       Date:  2011-01-21       Impact factor: 5.594

Review 2.  A new era in reproductive medicine: consequences of third-party oocyte donation for maternal and fetal health.

Authors:  Shigeru Saito; Yasushi Nakabayashi; Akitoshi Nakashima; Tomoko Shima; Osamu Yoshino
Journal:  Semin Immunopathol       Date:  2016-06-20       Impact factor: 9.623

3.  Preconception ovarian reserve and placenta-mediated pregnancy complications among infertile women.

Authors:  Wendy Vitek; Jinhee Oh; Omar Mbowe; Sally W Thurston; Mindy S Christianson; Aaron K Styer; Alex J Polotsky; Michael P Diamond; Marcelle I Cedars
Journal:  Pregnancy Hypertens       Date:  2022-02-02       Impact factor: 2.899

4.  In vitro fertilisation (IVF) with donor eggs in post-menopausal women: are there differences in pregnancy outcomes in women with premature ovarian failure (POF) compared with women with physiological age-related menopause?

Authors:  Devini Ameratunga; Gareth Weston; Tiki Osianlis; James Catt; Beverley Vollenhoven
Journal:  J Assist Reprod Genet       Date:  2009-10-22       Impact factor: 3.412

5.  Corpus luteal contribution to maternal pregnancy physiology and outcomes in assisted reproductive technologies.

Authors:  Kirk P Conrad; Valerie L Baker
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2012-10-24       Impact factor: 3.619

6.  Perinatal outcomes of singleton siblings: the effects of changing maternal fertility status.

Authors:  Barbara Luke; Daksha Gopal; Howard Cabral; Hafsatou Diop; Judy E Stern
Journal:  J Assist Reprod Genet       Date:  2016-06-18       Impact factor: 3.412

7.  Determinants of Maternal Renin-Angiotensin-Aldosterone-System Activation in Early Pregnancy: Insights From 2 Cohorts.

Authors:  Rosalieke E Wiegel; A H Jan Danser; Régine P M Steegers-Theunissen; Joop S E Laven; Sten P Willemsen; Valerie L Baker; Eric A P Steegers; Frauke von Versen-Höynck
Journal:  J Clin Endocrinol Metab       Date:  2020-11-01       Impact factor: 5.958

Review 8.  Is oocyte donation a risk factor for preeclampsia? A systematic review and meta-analysis.

Authors:  Anna Blázquez; Désirée García; Amelia Rodríguez; Rita Vassena; Francesc Figueras; Valérie Vernaeve
Journal:  J Assist Reprod Genet       Date:  2016-03-23       Impact factor: 3.357

9.  The evolving landscape of donor egg treatment: success, women's choice, and anonymity.

Authors:  Alexandra Peyser; Stephanie Brownridge; Mary Rausch; Nicole Noyes
Journal:  J Assist Reprod Genet       Date:  2021-06-20       Impact factor: 3.357

10.  Adverse obstetric outcomes in pregnancies resulting from oocyte donation: a retrospective cohort case study in Sweden.

Authors:  Evangelia Elenis; Agneta Skoog Svanberg; Claudia Lampic; Alkistis Skalkidou; Helena Åkerud; Gunilla Sydsjö
Journal:  BMC Pregnancy Childbirth       Date:  2015-10-08       Impact factor: 3.007

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.